Cupid Shares Hit Record High; Stock Soars 15,400% In Five Years. Here's What Fuelling This Multibagger Stock
Add Preferred News Source
Cupid shares hit a record ₹368 on 9 October, taking their five-year gain to around 15,400%. The rally follows an increase in FY27 guidance to ₹800 crore in revenue and over ₹250 crore in net profit, alongside plans for manufacturing and distribution expansion.
Cupid shares climbed more than 3% on Friday, 9 October, to hit a fresh record high of ₹368 on the Bombay Stock Exchange (BSE). The stock has risen in seven of the past eight sessions, gaining around 39% during that stretch.
The rally has added to the stock's already massive gains. Cupid’s shares are up about 230% in 2026 so far and 656% over the past year. Over five years, the stock has surged nearly 15,400%.
The latest gains followed the company's decision to raise its revenue and profit guidance for FY27, citing strong business momentum and better visibility across domestic and international markets.
At 11:57 AM, Cupid's share price on the BSE stood at ₹362.35 apiece, up 1.60%.
Cupid Raises FY27 Revenue Guidance To ₹800 Crore
Cupid expects revenue for the September quarter of FY27 to cross ₹200 crore, according to an exchange filing dated 30 September 2026.
The company has raised its full-year revenue guidance to ₹800 crore and expects net profit to exceed ₹250 crore. Its earlier targets were revenue of ₹725-750 crore and net profit of ₹210-225 crore.
Cupid said the revised outlook reflects continued growth across its business segments, stronger visibility in institutional and private markets, and expansion in its domestic FMCG business. The company also expects its healthcare and personal care portfolio to keep growing through the second half of the financial year.
South Africa Manufacturing Plan Adds To Growth Prospects
Cupid has received in-principle approval for a manufacturing venture in South Africa. The proposed facility is expected to support local production and give the company a base for expanding into African and other overseas markets.
Cupid has also strengthened its healthcare partnership with GII Healthcare Investment Limited through an additional investment of $5 million.
Palava Facility And FMCG Expansion In Focus
The company is working towards operationalising its Palava manufacturing facility. The move is expected to improve production capacity and give it greater flexibility in meeting customer demand.
On the consumer side, Cupid plans to widen its FMCG distribution network across modern trade, general trade and pharmacy channels. The expansion is expected to support sales of its personal care and consumer healthcare products.
The company has pointed to growth across both its domestic consumer business and international business-to-business healthcare operations while revising its FY27 outlook.
Cupid Approves Warrant Conversion
During the September quarter, Cupid approved the conversion of up to 30 lakh warrants held by Baazar Style Retail Limited into an equivalent number of equity shares at ₹328.25 per share.
The conversion comes as the stock trades well above that price, having touched ₹368 on Friday. Investors will be watching whether the company can deliver the revenue and profit growth outlined in its revised guidance as the year progresses.
This article is for informational purposes only and should not be considered investment advice from Kotak Neo. For compliance T&C and disclaimers, Visit www.kotakneo.com/disclaimer
Vishwa has spent 10+ years across fintech and FMCG doing what most people miss, connecting the dots, catching trends before they trend, and finding the angle nobody else thought to ask about.
At Kotak Neo, she drives content strategy for neoshorts, Kotak News Desk, and Investing Guide, turning market noise into something worth reading.
When she's not decoding markets, she trades charts for canvases, chasing art, painting, and architecture across cities she's yet to explore.
Right Tools, Rich Insights
